"Anything that occurs in the younger age group indicates a burden in the future," Jemal said. "So, it is important to find out what is contributing to this increase so you can avert the future cancer burden."
In another report in the same journal, researchers with the Global Advanced/Adjuvant Stomach Tumor Research International Collaboration (GASTRIC) Group studied whether surgery alone or in combination with chemotherapy offered the best survival for stomach cancer patients. They looked at 17 clinical trials that included over 3,800 patients. Among 1,857 patients who had surgery, 1,067 died within seven years of the procedure, compared with 1,000 deaths among 1,924 patients who also had chemotherapy.
For more information on stomach cancer, visit the American Cancer Society.
SOURCES: Charles Rabkin, M.D., senior investigator, U.S. National Cancer Institute, Rockville, Md.; Ahmedin Jemal, D.V.M., Ph.D., strategic director for cancer occurrence, American Cancer Society; Jaffer A. Ajani, M.D., oncologist, Department of Gastrointestinal Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston; May 5, 2010, Journal of the American Medical Association
All rights reserved